1. Home
  2. PRO vs COLL Comparison

PRO vs COLL Comparison

Compare PRO & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRO
  • COLL
  • Stock Information
  • Founded
  • PRO 1985
  • COLL 2002
  • Country
  • PRO United States
  • COLL United States
  • Employees
  • PRO N/A
  • COLL N/A
  • Industry
  • PRO EDP Services
  • COLL Biotechnology: Pharmaceutical Preparations
  • Sector
  • PRO Technology
  • COLL Health Care
  • Exchange
  • PRO Nasdaq
  • COLL Nasdaq
  • Market Cap
  • PRO 898.3M
  • COLL 910.2M
  • IPO Year
  • PRO 2007
  • COLL 2015
  • Fundamental
  • Price
  • PRO $17.89
  • COLL $26.79
  • Analyst Decision
  • PRO Strong Buy
  • COLL Strong Buy
  • Analyst Count
  • PRO 10
  • COLL 5
  • Target Price
  • PRO $31.10
  • COLL $43.60
  • AVG Volume (30 Days)
  • PRO 615.5K
  • COLL 393.2K
  • Earning Date
  • PRO 05-01-2025
  • COLL 05-08-2025
  • Dividend Yield
  • PRO N/A
  • COLL N/A
  • EPS Growth
  • PRO N/A
  • COLL 43.56
  • EPS
  • PRO N/A
  • COLL 1.86
  • Revenue
  • PRO $330,372,000.00
  • COLL $631,449,000.00
  • Revenue This Year
  • PRO $10.12
  • COLL $19.96
  • Revenue Next Year
  • PRO $10.10
  • COLL $3.93
  • P/E Ratio
  • PRO N/A
  • COLL $14.31
  • Revenue Growth
  • PRO 8.78
  • COLL 11.41
  • 52 Week Low
  • PRO $14.81
  • COLL $23.23
  • 52 Week High
  • PRO $34.54
  • COLL $42.29
  • Technical
  • Relative Strength Index (RSI)
  • PRO 48.61
  • COLL 43.80
  • Support Level
  • PRO $15.22
  • COLL $25.87
  • Resistance Level
  • PRO $17.74
  • COLL $27.95
  • Average True Range (ATR)
  • PRO 0.89
  • COLL 1.50
  • MACD
  • PRO 0.35
  • COLL 0.05
  • Stochastic Oscillator
  • PRO 99.68
  • COLL 69.33

About PRO PROS Holdings Inc.

Pros Holdings Inc. is a provider of cloud-based revenue and profit realization software solutions to business-to-business and business-to-consumer companies. Its solutions assist customers in growing revenue, modernizing business processes, and supporting profitability by leveraging prescriptive analytics and data science-based decision-making technology. The company's solutions enable buyers to move fluidly across its customers' direct sales, partner, online, mobile, and emerging channels with personalized experiences. The firm generates revenue in the United States, Europe, Africa, Asia-Pacific, and Middle East regions.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: